Microfluidic Technologies: Biopharmaceutical and Healthcare Applications 2013-2023

June 2013 | 151 pages | ID: M4DA616FC82EN
Visiongain

Abstracts

Microfluidics - how to find trends, opportunities and revenue prospects

Do you want to assess the potential of microfluidic technologies? Visiongain's new report gives you revenue predictions there from 2013, helping you stay ahead. You find financial data, trends, opportunities, and outlooks.

In that work you see forecasted sales to 2023 at overall world market, submarket (application), and national level. You assess those trends and technologies for life sciences, pharmaceuticals, medical devices, and in vitro diagnostics.

Analysis of what shapes the microfluidics industry and determines its potential

Discover, then, what the future holds for microfluidics and its applications. Read on to explore that industry and see what its future market could be worth.

Forecasts to 2023 and other analyses show you commercial opportunities

Besides revenue forecasting to 2023, you see financial results, growth rates, and market shares. You assess quantitative and qualitative analysis, business news, outlooks, and developments (R&D). You also gain 48 tables, 46 charts, and two interviews.

Our work lets you investigate the most promising and lucrative parts of microfluidics, helping you stay ahead in knowledge. Finding data you need there just got easier.

Now see how you can benefit your research, analyses, and decisions, also saving time.

Prospects for the world market and submarkets

Our new report shows revenue to 2023 for the overall world market. It also shows you individual forecasts of 11 microfluidic submarkets. Find revenues to 2023 for these applications:

• In vitro diagnostics - with sub-forecasts for clinical diagnostics, point of care (POC) diagnostics, analytical devices, and other products
• Pharmaceutical and life science research - with sub-forecasts for genomics, proteomics, cell-based assays, and other products
• Drug delivery.

How will the microfluidics market expand? Which parts will most prosper? There you assess potential for sales.

Our study also discusses what stimulates and restrains that market. That analysis helps you identify potential and find ways for your business to benefit.

You find geographical revenue predictions too.

Forecasts of national markets for microfluidic technologies

In developed and developing countries, many sales opportunities for developers and producers of those technologies will occur from 2013. See where and how.

Our analyses show you individual revenue forecasts to 2023 for nine national markets and a regional block:

• US
• Japan
• Germany, France, UK, Italy, and Spain (EU5)
• EU (grouped regional forecast)
• India and China.

There you find potential for the technology. Pharma and diagnostics companies face many opportunities worldwide. Our study explains, discussing crucial issues.

Developments and opportunities affecting microfluidics

Our report discusses issues and events affecting that industry and market from 2013:

• Products in development - R&D and expanding applications
• Microfluidic technologies and products available
• Lab-on-a-chip technology, with wide range of biological uses
• Production of devices - manufacturing issues
• Regulation of microfluidic devices - the US and Europe.

That study also discusses other aspects of the field, including these:

• Academia and industry - gaps and connections
• Demand for advanced drug delivery methods
• Microfluidics benefitting the biologics industry
• Drug development - including genomics, proteomics, and cell-based assays
• Delivery of drugs and vaccines - including microneedles, micropumps, and inhalers
• Personalised medicine and stem cells.

There, you explore that industry's strengths, weaknesses, opportunities, and threats. You see what stimulates and restrains technology and business.

See, then, what the future holds.

Prominent companies in that biomedical field and its 2017 market value

What happens next? Our study predicts the world market for microfluidics will reach $3.5bn in 2017 - with strong growth - and expand further to 2023. See how high revenues can go.

That work shows you what tecnologies, products, and organisations hold greatest potential. Our analysis investigates these companies and many others:

• Agilent Technologies
• PerkinElmer
• Cepheid
• Fluidigm Corporation.

In our study you find 192 organisations covered. Also, you read two interviews with authorities in that industry. See what shapes it, discovering what participants do and say.

Microfluidic technologies hold great potential for investment, development, and revenue growth from 2013. You see how they can progress, benefiting companies.

Eight ways Microfluidic Technologies: Biopharmaceutical and Healthcare Applications 2013-2023 helps you

To sum up, our analysis gives you the following knowledge:

• Revenue to 2023 for the world microfluidics market - discover that industry's overall sales potential
• Revenues to 2023 for 11 world-level submarkets - investigate the potential of its applications, finding the most promising places for investments and revenues
• Forecasts to 2023 for 9 national markets in North America, Europe, and Asia - find the best countries for revenues and potential growth
• Discussions and data for companies - hear about developers and manufacturers' activities, capabilities, results, and outlooks
• Review of R&D and prospects for market expansion - investigate developments, exploring possibilities for technological and commercial advances
• Interviews with experts on microfluidics - discover what authorities in that field think, say, and do, helping you stay ahead
• Analysis of what stimulates and restrains that industry and market - assess challenges and strengths, helping you compete and gain advantages
• Prospects for established players and companies entering that sector - explore needs, practices and outlooks for future success.

Information found nowhere else

That work gives independent analysis. You receive business intelligence found only in our report, seeing where prospects are most rewarding.

With our study you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.

Assess progress and potential in microfluidics now, seeing what you can gain.

Microfluidics - discover technological and commercial prospects by ordering now

Our study is for everyone investigating microfluidic technologies. There you find data, trends, opportunities, and sales predictions. Avoid missing out - please order our new report now.

Contents

1. EXECUTIVE SUMMARY

1.1 Overview of Microfluidics Technology Market
1.2 Aim, Scope and Format of this Report
1.3 Chapters in the Report
1.4 Research and Analysis Methods
1.5 Glossary of Terms Relating to the Microfluidics Technology Market

2. INTRODUCTION TO MICROFLUIDICS TECHNOLOGY

2.1 What is Microfluidics?
  2.1.1 History of Microfluidics Technology
  2.1.2 Continuous Flow Microfluidics
  2.1.3 Digital Microfluidics
2.2 Benefits of Microfluidics Technology
2.3 Fabrication of Microfluidic Devices
2.4 Where Does Microfluidics Technology Find Applications?
2.5 The Microfluidic Technologies Market
  2.5.1 Microfluidics Technology in the In Vitro Diagnostics Market
    2.5.1.1 Clinical Diagnostics
    2.5.1.2 Point of Care (POC) Diagnostics
    2.5.1.3 Analytical Devices
  2.5.2 Microfluidics Technology in Pharmaceutical and Life Science Research
    2.5.2.1 Genomics
    2.5.2.2 Proteomics
    2.5.2.3 Cellular Assays
  2.5.3 Microfluidics Technology in Drug Delivery
    2.5.3.1 Increasing Popularity of Transdermal Drug Delivery
    2.5.3.2 Microneedles
    2.5.3.3 Micropumps
    2.5.3.4 Inhalers
2.6 Regulation of Microfluidic Devices
  2.6.1 The US Regulation System
  2.6.2 Regulation of Laboratory Developed Tests
  2.6.3 The European Regulatory System
    2.6.3.1 Post Marketing Surveillance in the EU

3. THE GLOBAL MICROFLUIDIC TECHNOLOGIES MARKET, 2013-2023

3.1 Microfluidic Technologies Market: Overview
3.2 Microfluidic Technologies Market by Segment, 2012
3.3 Microfluidic Technologies Market Forecast, 2013-2023
3.4 Microfluidic Technologies Market Trends, 2013-2023
  3.4.1 Increase in Chronic Disease Patient Population
  3.4.2 Shift towards Decentralisation
  3.4.3 Increased Awareness through Globalisation
  3.4.4 Growing Demand for Advanced Drug Delivery Methods
  3.4.5 Microfluidics Technology Benefitting Biologics Market
  3.4.6 Move towards Personalised Medicine
  3.4.7 Fast Changing Market

4. MICROFLUIDICS TECHNOLOGY IN THE WORLD IN VITRO DIAGNOSTICS MARKET, 2013-2023

4.1 Microfluidics Based IVD Market: Overview
4.2 Microfluidics Based IVD Market by Segment, 2012
4.3 Microfluidics Based IVD Market Forecast, 2012-2017
4.4 Microfluidics Based IVD Market Forecast, 2017-2023
4.5 Microfluidics Based Clinical Diagnostics Market, 2012
  4.5.1 Microfluidics Based Clinical Diagnostics Market Forecast, 2012-2023
4.6 Microfluidics Based POC Diagnostics Market, 2012
  4.6.1 Microfluidics Based POC Diagnostics Market Forecast, 2012-2023
  4.6.2 Leading Microfluidics Based POC Devices in the Market, 2013
  4.6.3 Microfluidics Based POC Devices in Development, 2013
4.7 Microfluidics Based Analytical Devices Market, 2012
  4.7.1 Microfluidics Based Analytical Devices Market Forecast, 2012-2023
  4.7.2 Leading Microfluidics Based Analytical Devices in Market, 2013
4.8 Conclusions

5. MICROFLUIDICS TECHNOLOGY IN PHARMACEUTICAL AND LIFE SCIENCE RESEARCH MARKET, 2013-2023

5.1 Microfluidics Based Pharmaceutical and Life Science Research Market: Overview
5.2 Microfluidics Based Pharmaceutical and Life Science Research Market by Segment, 2012
5.3 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast, 2012-2017
5.4 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast, 2017-2023
5.5 Microfluidics Based Genomics Market, 2012
  5.5.1 Microfluidics Based Genomics Market Forecast, 2012-2023
5.6 Microfluidics Based Proteomics Market, 2012
  5.6.1 Microfluidics Based Proteomics Market Forecast, 2012-2023
5.7 Microfluidics Based Cell-Based Assays Market, 2012
  5.7.1 Microfluidics Based Cell-Based Assays Market Forecast, 2012-2023
5.8 Leading Microfluidics Based Pharmaceutical and Life Science Research Devices in Market, 2013
  5.8.1 LabChip: A Highly Advanced Research Platform
  5.8.2 2100 Bioanalyzer: Preferred Standard in a Research Lab
  5.8.3 Microcapillary Protein Crystallisation System Plug Maker (Emerald Biosystems)
  5.8.4 BioMark (Fluidigm Corporation)
  5.8.5 C1 Single-Cell Auto Prep System (Fluidigm Corporation)
  5.8.6 QX100ddPCR: A Leading Device in Digital PCR Technology
  5.8.7 RainDrop System (RainDance Technologies)
  5.8.8 Mondrian SP (NuGEN)
  5.8.9 IonPGM Sequencer (Life Technologies)
  5.8.10 Genome Analyzer (Illumina)
5.9 Conclusions

6. MICROFLUIDICS TECHNOLOGY IN THE DRUG DELIVERY MARKET, 2013-2023

6.1 Microfluidics Based Drug Delivery Market: Overview
6.2 Market Projection for Microfluidics Based Drug Delivery Market, 2012-2023
6.3 Leading Microfluidics Based Drug Delivery Devices in Market, 2013
  6.3.1 MiniMed Paradigm Revel System: A Leading Insulin Pump
  6.3.2 MicronJet (Nanopass Technologies)
  6.3.3 Nanoject: A Device for Intradermal Vaccine Delivery
  6.3.4 Microstructured Transdermal System (MTS) Device
  6.3.5 Respimat: A New Generation Inhaler
  6.3.6 Spray Nozzles for Aerosol Inhaler Devices
6.4 Microfluidics Based Drug Delivery Devices in Development, 2013
  6.4.1 Nanopump: A Miniaturised Drug Delivery Pump
  6.4.2 JewelPUMP: Hoping to Revolutionise the Life of Diabetic Patients
  6.4.3 SOLO Micropump: Smallest and Lightest Insulin Pump
  6.4.4 AdminPen: New Liquid Injection System
  6.4.5 PKA SoftTouch Microneedle: Breakthrough from PKA SoftTouch Corp?
  6.4.6 DrugMAT: Microneedle Patch for Drug/Vaccine Delivery
  6.4.7 MicroCor: Minimally Invasive Drug/Vaccine Delivery System
  6.4.8 Implantable Drug Delivery Device
6.5 Conclusions

7. LEADING NATIONAL MICROFLUIDIC TECHNOLOGIES MARKETS, 2013-2023

7.1 Regional Breakdown of the Microfluidic Technologies Market, 2012
7.2 Microfluidic Technologies Market: Regional Forecast 2012-2023
7.3 The US 2012-2023: Leading National Market
7.4 Europe 2012-2023: Analysis of EU5
  7.4.1 Germany 2012-2023: Largest European Market
  7.4.2 France 2012-2023: Patient Demographics will Push Market Growth
  7.4.3 Italy 2012-2023: Slow Growth Owing to Economic Crisis
  7.4.4 Spain 2012-2023: Facing Cost Containment Measures
  7.4.5 UK 2012-2023: Budgetary Constraints
7.5 Japan 2012-2023: Second Largest National Market in 2012
7.6 China 2012-2023: Potential for Strong Growth
7.7 India 2012-2023: Fastest Growing National Market

8. LEADING COMPANIES IN THE MICROFLUIDIC TECHNOLOGIES INDUSTRY, 2013

8.1 Agilent Technologies
  8.1.1 Sales and Performance Analysis, 2012
  8.1.2 Diagnostics and Genomics Business Analysis, 2012
  8.1.3 Sales and Performance Analysis by Region, 2012
8.2 PerkinElmer
  8.2.1 Sales and Performance Analysis, 2012
  8.2.2 Human Health Segment Analysis, 2012
8.3 Cepheid
  8.3.1 Sales and Performance Analysis, 2012
  8.3.2 Product Sales by Category, 2012
  8.3.3 Product Sales by Region, 2012
8.4 Fluidigm Corporation
  8.4.1 Sales and Performance Analysis, 2012
  8.4.2 Product Sales Analysis by Segment, 2012
  8.4.3 Product Sales by Region, 2012
8.5 Other Companies, 2013

9. SWOT ANALYSIS OF THE MICROFLUIDIC TECHNOLOGIES MARKET, 2013-2023

9.1 Strengths
  9.1.1 Increase in Prevalence of Diseases Worldwide
  9.1.2 Ability to Fit an Entire Lab on to a Chip
  9.1.3 Wide Range of Biological Applications
9.2 Weaknesses
  9.2.1 Microfluidics Remains an Emerging Field
  9.2.2 The Gap between Academia and Industry
  9.2.3 Limited Adoption of Microfluidics Technology
9.3 Opportunities
  9.3.1 Growth of Personalised Medicine
  9.3.2 Microfluidic Devices for Stem Cell Research
  9.3.3 Point of Care Diagnostics Poised for Strong Growth
  9.3.4 Expansion into Developing National Markets
9.4 Threats
  9.4.1 Complexity of Microfluidic Devices Posing Regulatory Challenges
  9.4.2 Lack of Sufficient Healthcare Coverage
  9.4.3 Medical Device Excise Tax

10. RESEARCH INTERVIEWS

10.1 Interview with CYTOO Cell Architects
  10.1.1 The Current State of the Microfluidics Technology Market
  10.1.2 Role of Microfluidics in Cell-Based Assays
  10.1.3 Major Challenges Faced by Microfluidics Technology
  10.1.4 The Outlook for Microfluidics Technology
10.2 Interview with GeneFluidics
  10.2.1 About GeneFluidics
  10.2.2 Microfluidics Technology Market Environment
  10.2.3 Impact of Microfluidics Technology on Personalised Medicine
  10.2.4 Obstacles to Market Growth

11. CONCLUSIONS OF THE STUDY

11.1 The Microfluidic Technologies Market, 2013-2023
11.2 The IVD Market
11.3 The Pharmaceutical and Life Science Research Market
11.4 The Drug Delivery Market
11.5 Concluding Remarks

List Of Tables

LIST OF TABLES

Table 3.1 Microfluidic Technologies Market: Sales ($m) and Market Shares (%) by Segment, 2012
Table 3.2 Microfluidic Technologies Market Forecast ($m, %) by Segment, 2012-2017
Table 3.3 Microfluidic Technologies Market Forecast ($m, %) by Segment, 2017-2023
Table 3.4 Key Mergers and Acquisitions in the Microfluidic Technologies Market, 2011
Table 4.1 Microfluidics Based IVD Market: Sales ($m) and Market Shares (%), 2012
Table 4.2 Microfluidics Based IVD Market Forecast ($m, %), 2012-2017
Table 4.3 Microfluidics Based IVD Market Forecast ($m, %), 2017-2023
Table 4.4 Microfluidics Based Clinical Diagnostics: Market Forecast ($m, %), 2012-2017
Table 4.5 Microfluidics Based Clinical Diagnostics: Market Forecast ($m, %), 2017-2023
Table 4.6 Microfluidics Based POC Diagnostics: Market Forecast ($m, %), 2012-2017
Table 4.7 Microfluidics Based POC Diagnostics: Market Forecast ($m, %), 2017-2023
Table 4.8 Leading Microfluidics Based POC Devices in the Market, 2013
Table 4.9 Microfluidics Based POC Devices in Development, 2013
Table 4.10 Microfluidics Based Analytical Devices: Market Forecast ($m, %), 2012-2017
Table 4.11 Microfluidics Based Analytical Devices: Market Forecast ($m, %), 2017-2023
Table 4.12 Leading Microfluidics Based Analytical Devices in the Market, 2013
Table 5.1 Microfluidics Based Pharmaceutical and Life Science Research Market: Sales ($m) and Market Shares (%) by Segment, 2012
Table 5.2 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast ($m, %) by Segment, 2012-2017
Table 5.3 Microfluidics Based Pharmaceutical and Life Science Research Market Forecast ($m, %) by Segment, 2017-2023
Table 5.4 Microfluidics Based Genomics Market Forecast ($m, %), 2012-2017
Table 5.5 Microfluidics Based Genomics Market Forecast ($m, %), 2017-2023
Table 5.6 Microfluidics Based Proteomics Market Forecast ($m, %), 2012-2017
Table 5.7 Microfluidics Based Proteomics Market Forecast ($m, %), 2017-2023
Table 5.8 Microfluidics Based Cell-Based Assay Market Forecast ($m, %), 2012-2017
Table 5.9 Microfluidics Based Cell-Based Assay Market Forecast ($m, %), 2017-2023
Table 5.10 Leading Microfluidics Based Pharmaceutical and Life Science Research Devices in Market, 2013
Table 6.1 Microfluidics Based Drug Delivery: Market Forecast ($m, %), 2012-2017
Table 6.2 Microfluidics Based Drug Delivery: Market Forecast ($m, %), 2017-2023
Table 6.3 Leading Microfluidics Based Drug Delivery Devices in the Market, 2013
Table 6.4 Microfluidics Based Drug Delivery Devices in Development, 2013
Table 7.1 Leading National Microfluidic Technologies Market: Sales ($m) and Market Shares (%), 2012
Table 7.2 Microfluidic Technologies: Market Forecasts ($m, %) by Leading Country, 2012-2017
Table 7.3 Microfluidic Technologies: Market Forecasts ($m, %) by Leading Country, 2017-2023
Table 7.4 European Microfluidic Technology Markets: Sales ($m) and Market Shares (%) in Leading National Markets, 2012
Table 7.5 European Microfluidic Technology Markets: Forecasts ($m, %) by Leading Country, 2012-2017
Table 7.6 European Microfluidic Technology Markets: Forecasts ($m, %) by Leading Country, 2017-2023
Table 8.1 Agilent Technologies: Net Revenue ($bn) and Revenue Shares (%) by Business Group, 2012
Table 8.2 Agilent Technologies: Net Revenue ($bn) and Revenue Shares (%) by Region, 2012
Table 8.3 PerkinElmer: Revenue ($bn) and Revenue Shares (%) by Segment, 2012
Table 8.4 Cepheid: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 8.5 Cepheid: Revenue ($m) and Revenue Shares (%) by Product Category, 2012
Table 8.6 Cepheid: Revenue ($m) and Revenue Shares (%) by Region, 2012
Table 8.7 Fluidigm Corporation: Revenue ($m) and Revenue Shares (%) by Segment, 2012
Table 8.8 Fluidigm Corporation: Revenue ($m) and Revenue Shares (%) by Product Segment, 2012
Table 8.9 Fluidigm Corporation: Revenue ($m) and Revenue Shares (%) of Products by Region, 2012
Table 8.10 Other Companies in the Microfluidic Technologies Market, 2013
Table 9.1 SWOT Analysis of the Microfluidic Technologies Market, 2013
Table 11.1 Segments in the Microfluidic Technologies Market: Sales ($m) in 2012, 2017, 2019 and 2023

About

Microfluidics Based POC Diagnostics Market Forecast, 2012-2023

The microfluidics based POC diagnostic segment generated sales worth $247m in 2012. Visiongain predicts the market for POC diagnostics will experience strong growth, reaching $633m in 2017 and $1,779m in 2023. A key factor in the growth of the overall POC diagnostics market is the concept of personalised medicine which encourages patients to be involved in their own care. In the initial part of the forecast period, the market will be primarily driven by well established devices like iSTAT handheld system manufactured by Abbottand Triage meter, developed by Alere. iSTAT system combines miniature fluidics and electrochemical detection to perform clinical chemistry measurements and few immunoassays. Triage meter is a portable and disposable capillary driven microfluidic test strip used for diagnosis of cardiovascular disease, drugs of abuse and waterborne parasites. Another interesting device incorporating microfluidics with lateral flow is the AlcNow test for diabetic patients. Paper based microfluidic devices being developed by Diagnostics For All will benefit diagnostics in low-income countries.

Claros Diagnostics has recently reported simultaneous diagnosis of HIV and syphilis using its microfluidic chips (mChip) in Rwanda. Visiongain predicts that the demand for microfluidics based POC devices will remain high, driven by its potential to detect analytes at very low concentrations. Currently, tests like lateral flow immunoassays can detect only those analytes present at high concentrations, which makes it incapable to detect diseases at its onset. The merging of microfluidics in to POC overcomes many of the challenges faced by the current POC tests. By 2017, we predict the market to grow to $633m, growing with a CAGR of 20.7% from 2012-2017. Developed countries such as the US, Europe and Japan will mainly drive growth in the first half of the forecast period. 

The second half of the forecast from 2017-2023 will be driven by the launch of a number of devices in the pipeline. The market will be primarily driven by low cost microfluidics based POC devices being developed for low income countries. In developing countries, there is a high burden of infectious diseases, many of which can be treated or prevented if diagnosis is done on time. This is where lab-on-chip POC tests will be increasingly used in the coming years. Several companies are involved in the development of novel microfluidic CD4+ T-cell counters for HIV/AIDS. An example is PimaCD4 counter developed by Alere through its subsidiary ClonDiag. Daktari Diagnostics is the other company pursuing an alternative approach to image-based CD4 cytometry. Paper based microfluidics will also find increased application in developing countries. Visiongain believes that microfluidics based POC diagnostics will grow strongly during 2017-2023, growing to $1,779 by 2023.